Wolverine Trading
ICPT

Wolverine Trading’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Wolverine Trading’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,500
Closed -$140K – 5290
2023
Q2 		$140K Sell
12,500
-2,200
-15% -$30.7K ﹤0.01% 3658
2023
Q1 		$198K Buy
+14,700
New +$254K ﹤0.01% 3425
2022
Q3 		– Sell
-19,700
Closed -$269K – 5578
2022
Q2 		$269K Buy
19,700
+6,500
+49% +$104K ﹤0.01% 3188
2022
Q1 		$214K Sell
13,200
-10,500
-44% -$164K ﹤0.01% 4334
2021
Q4 		$387K Buy
23,700
+2,800
+13% +$47.2K ﹤0.01% 3802
2021
Q3 		$317K Buy
20,900
+3,200
+18% +$51.2K ﹤0.01% 4624
2021
Q2 		$373K Sell
17,700
-900
-5% -$17.8K ﹤0.01% 4114
2021
Q1 		$421K Sell
18,600
-7,000
-27% -$195K ﹤0.01% 3972
2020
Q4 		$655K Sell
25,600
-1,000
-4% -$33.1K ﹤0.01% 2853
2020
Q3 		$1.11M Sell
26,600
-4,300
-14% -$198K ﹤0.01% 1975
2020
Q2 		$1.44M Sell
30,900
-2,600
-8% -$201K ﹤0.01% 1664
2020
Q1 		$2.18M Sell
33,500
-35,200
-51% -$3.16M 0.01% 1277
2019
Q4 		$8.48M Sell
68,700
-11,800
-15% -$1.06M 0.02% 753
2019
Q3 		$5.16M Buy
80,500
+200
+0.2% +$13.4K 0.01% 855
2019
Q2 		$6.39M Sell
80,300
-51,100
-39% -$4.57M 0.02% 753
2019
Q1 		$14.7M Buy
131,400
+48,900
+59% +$5.34M 0.04% 355
2018
Q4 		$7.76M Buy
82,500
+26,100
+46% +$2.71M 0.02% 579
2018
Q3 		$7.13M Buy
56,400
+6,500
+13% +$688K 0.02% 748
2018
Q2 		$3.07M Hold
49,900
– – 0.01% 1234
2018
Q1 		$3.07M Buy
+49,900
New +$3.01M 0.01% 1234
2017
Q3 		– Sell
-44,900
Closed -$5.51M – 5223
2017
Q2 		$5.51M Sell
44,900
-3,800
-8% -$440K 0.03% 623
2017
Q1 		$5.5M Sell
48,700
-22,600
-32% -$2.64M 0.03% 605
2016
Q4 		$7.75M Buy
71,300
+17,000
+31% +$2.03M 0.04% 499
2016
Q3 		$8.7M Sell
54,300
-800
-1% -$126K 0.04% 489
2016
Q2 		$8.26M Buy
+55,100
New +$8.03M 0.05% 427

Other funds holding ICPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Wolverine Trading's ICPT Position: Q2 2023 in Review

Wolverine Trading sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2023, closing a stake of 10,482 shares — an estimated $146K sold.

Wolverine Trading first reported a position in ICPT in Q1 2017 and held it in 14 quarters. The position peaked at $4.73M in Q1 2019. 126 funds tracked by Wall St. Rank hold ICPT as of Q2 2023.

  • Wolverine Trading reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Wolverine Trading sold 10,482 Intercept Pharmaceuticals, Inc. shares in Q2 2023, an estimated $146K.
  • Wolverine Trading first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2017 and held it in 14 quarters.
  • Wolverine Trading's Intercept Pharmaceuticals, Inc. position peaked at $4.73M in Q1 2019.
  • 126 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2023.

Based on Wolverine Trading's 13F filing for Q2 2023, filed 23 Aug 2023.